Jasper Therapeutics Stock Market Value
| JSPRW Stock | USD 0.22 0.01 4.76% |
| Symbol | Jasper |
Jasper Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jasper Therapeutics. If investors know Jasper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jasper Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.84) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Jasper Therapeutics is measured differently than its book value, which is the value of Jasper that is recorded on the company's balance sheet. Investors also form their own opinion of Jasper Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Jasper Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jasper Therapeutics' market value can be influenced by many factors that don't directly affect Jasper Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jasper Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jasper Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jasper Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Jasper Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Jasper Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Jasper Therapeutics.
| 01/06/2023 |
| 11/26/2024 |
If you would invest 0.00 in Jasper Therapeutics on January 6, 2023 and sell it all today you would earn a total of 0.00 from holding Jasper Therapeutics or generate 0.0% return on investment in Jasper Therapeutics over 690 days. Jasper Therapeutics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem ce... More
Jasper Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Jasper Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Jasper Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.09 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 28.18 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 10.0 |
Jasper Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jasper Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Jasper Therapeutics' standard deviation. In reality, there are many statistical measures that can use Jasper Therapeutics historical prices to predict the future Jasper Therapeutics' volatility.| Risk Adjusted Performance | 0.0142 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.92) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0265 |
Jasper Therapeutics Backtested Returns
Jasper Therapeutics is out of control given 3 months investment horizon. Jasper Therapeutics holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 17.03% are justified by taking the suggested risk. Use Jasper Therapeutics Risk Adjusted Performance of 0.0142, market risk adjusted performance of 0.0365, and Downside Deviation of 10.09 to evaluate company specific risk that cannot be diversified away. Jasper Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.27, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Jasper Therapeutics will likely underperform. Use Jasper Therapeutics potential upside, as well as the relationship between the accumulation distribution and price action indicator , to analyze future returns on Jasper Therapeutics.
Auto-correlation | -0.15 |
Insignificant reverse predictability
Jasper Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Jasper Therapeutics time series from 6th of January 2023 to 17th of December 2023 and 17th of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Jasper Therapeutics price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Jasper Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Jasper Therapeutics lagged returns against current returns
Autocorrelation, which is Jasper Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Jasper Therapeutics' stock expected returns. We can calculate the autocorrelation of Jasper Therapeutics returns to help us make a trade decision. For example, suppose you find that Jasper Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Jasper Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Jasper Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Jasper Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Jasper Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Jasper Therapeutics Lagged Returns
When evaluating Jasper Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Jasper Therapeutics stock have on its future price. Jasper Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Jasper Therapeutics autocorrelation shows the relationship between Jasper Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Jasper Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.